Open Access

Integrated analysis of lncRNA CTD‑2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma

  • Authors:
    • Bo Zou
    • Xin Guan
    • Wen Zhang
    • Dong Wang
    • Kai Xu
    • Dao‑Ying Yuan
    • Zhen Meng
    • Bin Zhang
  • View Affiliations

  • Published online on: September 25, 2019     https://doi.org/10.3892/ol.2019.10920
  • Copyright: © Zou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Head and neck squamous cell carcinoma (HNSCC), one of the most common malignant tumors, endangers human health. Recently, the incidence of HNSCC has kept increasing: However, its prognosis has not significantly improved. Understanding the molecular mechanism underlying HNSCC development will therefore provide new strategies for therapy. The present study attempted to identify differentially expressed (DE) long non‑coding (lnc)RNAs and investigated their functional role in HNSCC development. Expression profiles of HNSCC and normal samples were downloaded from The Cancer Genome Atlas (TCGA) database. DElncRNAs between the HNSCC and normal samples were highlighted and their potential functions were investigated through lncRNA‑micro (mi)RNA‑mRNA network by using Gene Expression Profiling Interactive Analysis, UALCAN, DIANA‑LncBase v.2 and miRWalk 3.0 databases. A total of 343 dysregulated lncRNAs were identified. Among these DElncRNAs, CTD‑2357A8.3 had the highest fold‑change and was significantly associated with poor overall survival in patients with HNSCC. Furthermore, CTD‑2357A8.3 was associated with ‘signaling pathways regulating stem cell pluripotency’, ‘proteoglycans in cancer’, ‘transcriptional misregulation in cancer’ and ‘chemokine signaling pathway’. Further analysis demonstrated that CTD‑2357A8.3 acted as a ‘sponge’ in order to competitively adsorb miRNA to regulate the expression of target gene caveolin 1 (CAV1) in HNSCC. In conclusion, CTD‑2357A8.3 may be considered a promising diagnosis biomarker or a therapeutic target for the treatment of HNSCC.

Related Articles

Journal Cover

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zou, B., Guan, X., Zhang, W., Wang, D., Xu, K., Yuan, D. ... Zhang, B. (1899). Integrated analysis of lncRNA CTD‑2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma. Oncology Letters, 0, 0-0. https://doi.org/10.3892/ol.2019.10920
MLA
Zou, B., Guan, X., Zhang, W., Wang, D., Xu, K., Yuan, D., Meng, Z., Zhang, B."Integrated analysis of lncRNA CTD‑2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma". Oncology Letters 0.0 (1899): 0-0.
Chicago
Zou, B., Guan, X., Zhang, W., Wang, D., Xu, K., Yuan, D., Meng, Z., Zhang, B."Integrated analysis of lncRNA CTD‑2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma". Oncology Letters 0, no. 0 (1899): 0-0. https://doi.org/10.3892/ol.2019.10920